In ibuprofen-treated gastric cancer cells, observed YTHDF2 level increase, p75NTR level increase and p75NTR promoter methylation decrease indicated that ibuprofen might increase the expression of p75NTR through low promoter methylation rather than ibuprofen-induced degradation of p75NTR. The gene discussed is YTHDF2; the disease is gastric cancer.